Find a TenderAwarded

Published 15 Dec 2021, 22:45 GMT

Official UK procurement notice

Proprietary Drugs · UK public procurement notice

Authority: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) (NHS & healthcare)·Consortium: 2 public authorities

GoodsOpen procedure

Sectors: Medical Devices & Pharma (33) Delivery: UKWales (UKL)

Awarded value£58,782,55220 contracts · exc. VAT

Submissions closed 21 Jan 2022awarded 11 Jul 2022

Awarded to Abbvie Ltd +9 more10 awards

Contract term 2 yrsends 30 Jun 2024 · extension options published · starts 1 Jul 2022

What is being bought

Published requirement description

Proprietary Drugs

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Lot #1AwardedRenewal 2 yrs

Contract period: 1 Jul 2022 – 30 Jun 2024 (2 yrs)

Delivery: UK, Wales

Extensions: There is a possibility to extend up to a further 24 monthsVariant bids: allowed

What it takes to win
i
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more

How bids were scored

Price: 60

Published sub-criteria (4)

Price: 30
VFM: 20
Price Stability: 6
Minimum Order: 4

Published award criteria (5)

Quality: Pass/Fail
Price: 30
VFM: 20
Price Stability: 6
Minimum Order: 4

Conditions of participation1

Suitability
Any supplier may be disqualified who does not respond to the following in the
requisite manner: 1. ENTERING GENERAL Qualification SUPPLIER INFORMATION NHS Wales
Shared Services Partnership Procurement Services utilizes the NHS Supplier Information Database (Sid4Gov)
and/or Sell2Wales to manage and assess general prequalification information in the form of a profile.
Candidates are requested to either: i) Provide their profile in Sid4Gov as follows: Candidates should
register on Sid4Gov at sid4gov.cabinetoffice.gov.uk/organisation/register ↗ and submit their
Sid4Gov company profile for publication to the system. Candidates already
registered on NHS Sid4Gov must ensure that information is up to date and provide
their profile number when responding to this alert. Where access to Sid4Gov is
unavailable, please contact the Sid4Gov helpdesk at [email protected] or ii) Register company information
on the Sell2Wales website at ww.sell2wales.co.uk. 2. SUBMISSION
OF TENDER AND PROCUREMENT SPECIFIC INFORMATION i) Candidates should register on the NHS Wales
Shared Services Partnership Procurement Services eTendering portal
etenderwales.bravosolution.co.uk/nhs ↗ ii) Once registered, candidates must
submit their tender as follows a) login to NHS Wales Shared Services Partnership
Procurement Services eTendering portal b) select 'Respond to OJEU advert and ITT c) select 'ITTs Open To
All Suppliers' d) access listing relating to the contract (title Anti-Retroviral Drugs) and view de…

What this means for your bid

Price carries 60 of 60 points: a 10% discount moves about 6 points. This one is won on the number: sharpen the price before polishing the prose.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Open procedure
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Competitive procedure
GPA / WTO covered: Unspecified in notice
Recurring procurement: Yes
First published: 15 Dec 2021, 22:45 GMT
Last source update: 14 Jul 2022, 14:25 BST
Award evaluation window: 21 Jan 2022 – …
FTS notice number: 2022/S 000-019289
Classification (CPV): Pharmaceutical products
Delivery area: UKWales (UKL)
Official registry OCID: ocds-h6vhtk-0301de Find a Tender

Publisher note: 1. The contracting authority reserves the right to use an electronic reverse auction. 2. If and when this requirement is offered for tender, this may be done in whole or in part via electronic means using the internet. 3. The contracting authority is not bound to award a contract in whole or part. 4. The contracting authority will not bear the tender costs of any of the tenderers. 5. In reference to I.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 6. This notice is being placed by NHS Wales Shared Services Partnership – Procurement Services. For the purpose of this procurement, the awarding authority will be Velindre NHS Trust. 7. This advertisement is placed by NHS Wales Shared Services Partnership - Procurement Services on behalf of participating LHB's/Trusts in Wales for the totality of those LHB/Trust specific contractual arrangements. 8. The Framework to be let for 2 years with an option to extend for up to 24 months.

How it was run

Official notice

Run through: Jaggaer · Who buys & how to bid on Sell2Wales

Supplier login requiredLanguage: EN

Access & registration note: Free; latest Chrome/Edge/Firefox only — corporate browsers fail

Submission deadline: 21 Jan 2022, 12:00 GMT
Submission channel: {"electronicSubmission","written"}
Accepted languages: en
Participation fee: document
Bids opened: 21 Jan 2022, 12:01 GMT

Detailed submission instructions & authority contactsFrom official release

www.etenderwales.bravosolution.co.uk/nhs/ ↗

Timeline

21 Jan 2022 → 14 Jul 2022 · 4 dates

Submission deadline
21 Jan 2022, 12:00 GMT
Bids opened
21 Jan 2022, 12:01 GMT
Contract starts
1 Jul 2022, 00:00 BST
Notice published
14 Jul 2022, 14:25 BST

Notice history

2 events · 2 releases on Find a Tender · since 14 Jul 2022

Status changed to complete
14 Jul 2022, 14:25 BST
Buyer details updated
14 Jul 2022, 14:25 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 69

Awarded value £58,782,55220 contracts exc. VAT

Bids received 78

Contracts signed 20latest 11 Jul 2022

Awarded to	Value	Date	Status
Abbvie Ltd	£879,259 †	—	Awarded
Astra Zeneca UK Ltd	£1,889,914 †	—	Awarded
Baxter Health Care Limited	£886,369 †	—	Awarded
Bayer Plc	£26,379,199 †	—	Awarded
Biogen Idec Ltd	£665,247 †	—	Awarded
Bristol Myers Squibb	£13,489,457 †	—	Awarded
Camurus AB	£1,605,902 †	—	Awarded
Celgene Ltd	£3,437,280 †	—	Awarded
Chiesi Limited	£932,284 †	—	Awarded
Chugai Pharma UK Ltd	£23,544 †	—	Awarded

59 further award records carry no date or value.

Contracts

Proprietary Drugs · Abbvie Ltd
Signed
11 Jul 2022
Value
£879,259
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Astra Zeneca UK Ltd
Signed
11 Jul 2022
Value
£1,889,914
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Baxter Health Care Limited
Signed
11 Jul 2022
Value
£886,369
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Bayer Plc
Signed
11 Jul 2022
Value
£26,379,199
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Biogen Idec Ltd
Signed
11 Jul 2022
Value
£665,247
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Bristol Myers Squibb
Signed
11 Jul 2022
Value
£13,489,457
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Camurus AB
Signed
11 Jul 2022
Value
£1,605,902
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Celgene Ltd
Signed
11 Jul 2022
Value
£3,437,280
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Chiesi Limited
Signed
11 Jul 2022
Value
£932,284
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs · Chugai Pharma UK Ltd
Signed
11 Jul 2022
Value
£23,544
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£6,200
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£383,541
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£58,100
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£414,830
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£44,247
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£18,500
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£12,533
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£7,588,303
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£7,281
Period
… – 30 Jun 2024
Status
active
Proprietary Drugs
Signed
11 Jul 2022
Value
£60,562
Period
… – 30 Jun 2024
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
78bids	—	—	—

Contracting authority & participating public bodies

2 public bodies on the notice

Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)

Contracting authorityNHS & healthcareBody governed by public lawHealth Procurement Services, 4th Floor, Companies House, Crown Way, Cardiff, Wales, CF14 3UBContact name, email, phone

Bidders & participating suppliers

69 commercial parties on the notice · 50 awarded

The first 50 of 69 commercial parties (by name); the JSON mirror lists them all.

AMO United Kingdom LtdAwarded supplier Wokingham, Wales
AbbVie LimitedAwarded supplier Maidenhead, Wales
Accord-UK LtdAwarded supplier Barnstaple, Wales
Alliance Pharmaceuticals LtdAwarded supplier Chippenham, Wales
Amgen LimitedAwarded supplier Cambridge, Wales
Amicus Therapeutics UK LtdAwarded supplier Marlow, Wales
Aspen Pharmacare UK LimitedAwarded supplier Maidenhead, Wales
Aspire Pharma LtdAwarded supplier Petersfield, Wales
Astella Pharma LtdAwarded supplier Egham, Wales
Astra Zeneca UK LtdAwarded supplier Luton, Wales

Show 40 more suppliers

Baxter Health Care LimitedAwarded supplier Newbury, Wales
Bayer PLCAwarded supplier Reading, Wales
Biogen Idec LimitedAwarded supplier Maidenhead, Wales
Bristol-Myers Squibb Pharmaceuticals LtdAwarded supplier Uxbridge, Wales
CIPLA EU LtdAwarded supplier Addlestone, Wales
CST PharmaAwarded supplier Walsall, Wales
Camurus ABAwarded supplier Lund, Wales
Celgene LtdAwarded supplier Uxbridge, Wales
Chiesi LimitedAwarded supplier Manchester, Wales
Chugai Pharma UK LimitedAwarded supplier London, Wales
Consilient Health LtdAwarded supplier Richmond-upon-Thames, Wales
Correvio GmbHAwarded supplier Bielefeld, Wales
Dr Falk Pharma UK LtdAwarded supplier Bourne End, Wales
Drugsrus LimitedAwarded supplier Harrow, Wales
Eisai LimitedAwarded supplier Hatfield, Wales
Eli Lilly & Company LtdAwarded supplier Basingstoke, Wales
Ferring Pharmaceuticals LtdAwarded supplier West Drayton, Wales
Flexipharm Austrading LtdAwarded supplier Bourne End, Wales
Flynn Pharma LtdAwarded supplier Stevenage, Wales
Galen LimitedAwarded supplier Craigavon, Wales
Gilead Sciences LimitedAwarded supplier London, Wales
Glaxo SmithklineAwarded supplier Uxbridge, Wales
Glenmark PharmaceuticalsAwarded supplier Watford, Wales
Intrapharm Laboratories LtdAwarded supplier Cookham Dean, Wales
Ipsen LimitedAwarded supplier Slough, Wales
Janssen LimitedAwarded supplier High Wycombe, Wales
Kent PharmaceuticalsAwarded supplier Ashford, Wales
Laboratories Almirall S.AAwarded supplier Uxbridge, Wales
Lupin Healthcare (UK) LimitedAwarded supplier Slough, Wales
MartindaleAwarded supplier Brentwood, Wales
Merck Sharp & Dohme (UK) LimitedAwarded supplier London, Wales
Mercury Pharmaceuticals LtdAwarded supplier London, Wales
Merz Pharma UK LtdAwarded supplier Hemel Hempstead, Wales
Morningside Pharmaceuticals LimitedAwarded supplier Loughborough, Wales
Napp Pharmaceutical Group LtdAwarded supplier Cambridge, Wales
Neon Healthcare LtdAwarded supplier Hertfordshire, Wales
Norgine Pharmaceuticals LimitedAwarded supplier Harefield, Wales
Novartis Pharmaceuticals UK LimitedAwarded supplier Camberley, Wales
Novo Nordisk Pharmaceuticals LtdAwarded supplier Gatwick, Wales
Orion PharmaAwarded supplier Newbury, Wales

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

Economic and financial selection criteriatenderEconomic and financial selection criteria
Technical selection criteriatenderTechnical selection criteria